S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
NASDAQ:CRON

Cronos Group Stock Forecast, Price & News

$4.16
-0.24 (-5.45%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.12
$4.40
50-Day Range
$4.21
$6.71
52-Week Range
$4.12
$15.83
Volume
2.55 million shs
Average Volume
3.58 million shs
Market Capitalization
$1.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.68
30 days | 90 days | 365 days | Advanced Chart
Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.


Cronos Group logo

About Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Headlines

Cronos Group Provides Bi-Weekly MCTO Status Update
December 3, 2021 |  finance.yahoo.com
TSX Plunges by Noon
December 3, 2021 |  ca.finance.yahoo.com
Cronos Group (NASDAQ:CRON) Sets New 12-Month Low at $4.47
November 29, 2021 |  americanbankingnews.com
Cronos Group (NASDAQ:CRON) Hits New 52-Week Low at $4.69
November 22, 2021 |  americanbankingnews.com
Cronos Group (NASDAQ:CRON) Shares Gap Up to $4.89
November 19, 2021 |  americanbankingnews.com
Why Tilray, Cronos, and Curaleaf Stocks Dropped Today
November 18, 2021 |  finance.yahoo.com
Cronos Group (NASDAQ:CRON) Stock Price Down 6.7%
November 18, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
665
Year Founded
N/A

Sales & Book Value

Annual Sales
$46.72 million
Book Value
$4.74 per share

Profitability

Net Income
$-73.14 million
Net Margins
-258.59%
Pretax Margin
-257.01%

Debt

Price-To-Earnings

Miscellaneous

Free Float
352,682,000
Market Cap
$1.55 billion
Optionable
Optionable

Company Calendar

Last Earnings
8/05/2021
Today
12/03/2021
Next Earnings (Estimated)
12/09/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.64 out of 5 stars

Medical Sector

993rd out of 1,390 stocks

Medicinals & Botanicals Industry

10th out of 19 stocks

Analyst Opinion: 2.8Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Cronos Group (NASDAQ:CRON) Frequently Asked Questions

Is Cronos Group a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cronos Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group
or view top-rated stocks.

How has Cronos Group's stock price been impacted by Coronavirus (COVID-19)?

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRON stock has decreased by 23.1% and is now trading at $4.16.
View which stocks have been most impacted by COVID-19
.

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Thursday, December 9th 2021.
View our earnings forecast for Cronos Group
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) released its quarterly earnings data on Thursday, August, 5th. The company reported $0.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.22. The company had revenue of $15.60 million for the quarter, compared to analyst estimates of $18.48 million. Cronos Group had a negative trailing twelve-month return on equity of 9.48% and a negative net margin of 258.59%. The company's quarterly revenue was up 57.6% on a year-over-year basis. During the same period in the previous year, the business posted ($0.31) EPS.
View Cronos Group's earnings history
.

What price target have analysts set for CRON?

6 analysts have issued 1-year price objectives for Cronos Group's shares. Their forecasts range from $5.00 to $12.50. On average, they expect Cronos Group's stock price to reach $8.17 in the next twelve months. This suggests a possible upside of 96.3% from the stock's current price.
View analysts' price targets for Cronos Group
or view top-rated stocks among Wall Street analysts.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Michael Ryan Gorenstein, Executive Chairman (LinkedIn Profile)
  • Kurt T. Schmidt, President & Chief Executive Officer
  • Robert L. Madore, Chief Financial Officer
  • Arye Weigensberg, Vice President-Research & Technology
  • Shannon Buggy, Senior Vice President & Global Head-People

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (0.46%), Capital World Investors (0.42%), Connor Clark & Lunn Investment Management Ltd. (0.35%), Dimensional Fund Advisors LP (0.29%), TD Asset Management Inc. (0.23%) and Public Sector Pension Investment Board (0.14%). Company insiders that own Cronos Group stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends for Cronos Group
.

Which institutional investors are selling Cronos Group stock?

CRON stock was sold by a variety of institutional investors in the last quarter, including Connor Clark & Lunn Investment Management Ltd., Two Sigma Investments LP, Citadel Advisors LLC, Two Sigma Advisers LP, TD Asset Management Inc., Jane Street Group LLC, Penserra Capital Management LLC, and Goldman Sachs Group Inc.. Company insiders that have sold Cronos Group company stock in the last year include Jason Marc Adler, and Michael Ryan Gorenstein.
View insider buying and selling activity for Cronos Group
or view top insider-selling stocks.

Which institutional investors are buying Cronos Group stock?

CRON stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Capital World Investors, Voloridge Investment Management LLC, Renaissance Technologies LLC, Vontobel Holding Ltd., Janney Montgomery Scott LLC, Public Sector Pension Investment Board, and Dynamic Technology Lab Private Ltd.
View insider buying and selling activity for Cronos Group
or or view top insider-buying stocks.

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $4.16.

How much money does Cronos Group make?

Cronos Group has a market capitalization of $1.55 billion and generates $46.72 million in revenue each year. The company earns $-73.14 million in net income (profit) each year or ($0.41) on an earnings per share basis.

How many employees does Cronos Group have?

Cronos Group employs 665 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

Where are Cronos Group's headquarters?

Cronos Group is headquartered at 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The company can be reached via phone at (416) 504-0004.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.